◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Pak Fah Yeow International Limited (0239) Financial History

Name: Pak Fah Yeow International Limited (0239) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-08-10

Pak Fah Yeow International Limited (0239) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Wan Chai, Hong Kong with about 100 employees. Its market capitalization is roughly HKD 732 million. In the fiscal year ended 2025-12-31, 0239 reported HKD 214M in revenue and HKD 91M in net income.

Pak Fah Yeow International Limited, an investment holding company, engages in manufacturing, marketing, and distributing healthcare products under the Hoe Hin brand name. The company operates through three segments: Healthcare, Property Investments, and Treasury Investments.

Interactive charts & full statements →

0239 Revenue & Earnings History — Annual Income Statement

Income statement	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Total Revenue	HKD 214M	HKD 237M	HKD 259M	HKD 147M	—
Gross Profit	HKD 185M	HKD 204M	HKD 219M	HKD 116M	—
Operating Income (EBIT)	HKD 110M	HKD 126M	HKD 143M	HKD 49M	—
Net Income	HKD 91M	HKD 79M	HKD 105M	HKD 30M	—

HKD; HKDM / HKDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

0239 Free Cash Flow History

Cash flow	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Dividends Paid	(HKD 58M)	(HKD 67M)	(HKD 48M)	(HKD 25M)	—

HKD; HKDM / HKDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

0239 Balance Sheet History

Balance sheet	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Total Assets	HKD 828M	HKD 843M	HKD 908M	HKD 823M	—
Total Liabilities	HKD 106M	HKD 111M	HKD 142M	HKD 116M	—

HKD; HKDM / HKDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 0239 viewer.

Other Companies in Drug Manufacturers - Specialty & Generic

COLL · Collegium Pharmaceutical, Inc. — $873 million
VETO · Vetoquinol SA — $824 million
ESPR · Esperion Therapeutics Inc — $819 million
1652 · Fusen Pharmaceutical Company Limited — $784 million
IRWD · Ironwood Pharmaceuticals, Inc. — $712 million
0950 · Lee's Pharmaceutical Holdings Limited — $642 million
WEED · Canopy Growth Corporation — $619 million
EVT · Evotec SE — $612 million

← 0237 All “0-9” companies 0240 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.